开发可控制的智能药物输送系统,有效治疗类风湿关节炎
Lei Wang1, Lei Xin2, Yuchen Cao1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
ACS applied materials & interfaces
|September 17, 2024
概括
一种新型纳米药物GF-TF精确地准了类风湿性关节炎 (RA) 的关节炎症. 这种智能系统使用成像来控制tofacitib的释放,最大限度地减少副作用,并提高RA患者的治疗疗效.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性炎症性关节疾病,导致软骨和骨损伤,严重影响患者的生活质量.
- 目前的RA治疗涉及系统性药物,由于广泛分布,具有副作用.
- 对于精确的RA管理而言,智能药物输送系统非常需要.
研究的目的:
- 开发一种新型的人工可控纳米药物,用于向性类风湿关节炎治疗.
- 为了实现实时监控和精确的,图像引导的药物释放.
- 为了研究托法西提布加载纳米药物 (GF-TF) 对于 RA 治疗的疗效.
主要方法:
- 使用托法西提布,酸,叶酸和Fe (III) 组装一个纳米药物 (GF-TF).
- 使用自相声学/磁共振成像 (自PA/MRI) 来实时跟踪纳米药物缩.
- 服用德胺 (DFO) 来触发受控的纳米药物分解和托法西提布释放.
主要成果:
- 在炎症关节病变中,GF-TF纳米药物成功积累.
- 自动PA/MRI启用实时监测纳米药物局部化和释放.
- 德费洛克萨明在化Fe(III时触发了托法西蒂布的受控释放,信号变化表明了这一点.
结论:
- 开发的GF-TF纳米药物在炎症关节中提供有效的药物聚合.
- 该系统通过自动PA/MRI提供实时监测和药物释放的精确控制.
- 这种方法为风湿性关节炎的向和控制治疗提供了一个新的策略.
相关概念视频
Drug Delivery: Miscellaneous Routes
329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
Drug Delivery: Overview
278
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
278
Drug Delivery: Parenteral Route
442
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
442
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98


